Research News and Research

RSS

SARS experts head to China

At the request of the Chinese Ministry of Health, WHO is today sending the first members of an international team to help investigate the source of SARS cases recently reported in Beijing and the eastern province of Anhui. The team, which is expected to begin work on Wednesday, will include experts in epidemiology, virology, infection control, and laboratory biosafety.

26 Apr 2004

Give your mum a mammogram for mothers day

This Mother's Day the Pennsylvania Breast Cancer Coalition (PBCC) and Commerce Bank invite you to think of all the women in your life: mothers, grandmothers, aunts, sisters, daughters, and friends.

26 Apr 2004

$Safer flooring lowers risk of hip fracture$

Safer flooring lowers risk of hip fracture

Elderly people living in residential homes are at significantly lower risk of hip fracture if they fall on carpeted wooden floors than onto any other type of flooring, researchers from the University of Edinburgh have found.

26 Apr 2004

Parkinson’s disease drug Pergolide effective in treating restless legs syndrome

Pergolide, a drug commonly used to treat Parkinson’s disease symptoms, has recently been shown to be effective in treating restless legs syndrome. Researchers from seven countries collaborated on the study, published in the April 27 issue of Neurology, the scientific journal of the American Academy of Neurology.

26 Apr 2004

Alzheimer’s drug has been shown to improve memory and cognition in multiple sclerosis (MS) patients

A drug widely used for treating dementia in Alzheimer’s patients has been shown to improve memory and cognition in multiple sclerosis (MS) patients who are mild to moderately cognitively impaired.

26 Apr 2004

UK vital ageing research

Researchers at the University of Reading are setting up a clinical database of healthy older people willing to take part in a wide range of important research projects which could help shape the future of healthcare for senior citizens.

26 Apr 2004

Students to study compounds shown to prevent cancer drug resistance and studying tomato genes and proteins

Michigan State University’s new Goldwater Scholars for 2004 have a lot of work ahead of them – studying compounds shown to prevent cancer drug resistance and studying tomato genes and proteins.

26 Apr 2004

Experimental immune-boosting drug interleukin-2 helps HIV Patients

National Institutes of Health (NIH) scientists report that brief, widely-spaced courses of the experimental immune-boosting drug interleukin-2 (IL-2) allow people with HIV to maintain near normal levels of a key immune system cell for long periods.

26 Apr 2004

SARS antibody sent to China

Responding to a request from a Chinese biotechnology company working closely with officials in China, Medarex, Inc. and the Massachusetts Biologic Laboratories (MBL) of the University of Massachusetts Medical School (UMMS) have shipped to Beijing a sample of the fully human antibody to SARS developed by Medarex and MBL/UMMS.

26 Apr 2004

New analytical approach that combines genetic and clinical data to give individualized prognosis of cancer recurrence

Researchers at Duke University have developed a new analytical approach that combines genetic and clinical data to give cancer patients an individualized prognosis of their cancer recurrence. The information could prove critical in deciding how aggressively to treat the disease following surgery.

26 Apr 2004

Scientists studying the adhesive properties of the neural cell adhesion molecule have found that two opposing models of cell adhesion are both correct

Scientists studying the adhesive properties of the neural cell adhesion molecule (NCAM) -- a protein that helps bind the nervous system together -- have found that two opposing models of cell adhesion are both correct.

26 Apr 2004

Heart disease and stroke hit younger in developing countries

A new report to be released at Columbia University's Earth Institute on April 26, 2004, suggests that heart disease and stroke are far more urgent threats to global health than commonly appreciated. They are causing hundreds of thousands of deaths each year in young people of productive age.

26 Apr 2004

Research yields new epilepsy guidelines

In conjunction with the AMA, the American Academy of Neurology and the American Epilepsy Society on April 26 jointly announced new guidelines for treating epilepsy. The number of anti-epileptic drugs has more than doubled in the last decade.

26 Apr 2004

New Saint Louis University research sheds light on how obesity occurs

Saint Louis University researchers believe they’ve won a major skirmish in the battle of the bulge, and their findings are published in the May issue of Diabetes.

26 Apr 2004

Smoking tobacco with a water pipe increasingly popular among women

Smoking tobacco using a water pipe - also called a hookah -- generally is viewed in a more positive light than smoking cigarettes, particularly for women, according to one of the first studies on water pipe and cigarette smoking to look at social attitudes and gender.

26 Apr 2004

UK Healthcare workers have new charitable way to protect adults and children with learning disabilities from abuse

Social workers and staff in the healthcare sector are being offered an easy way to pledge money to a national charity dedicated to the protection of adults and children with learning disabilities from the risk of abuse.

26 Apr 2004

UK Government ignoring scientific concerns over proposed Human Tissue Bill

The Royal Society today (Monday 26 April 2004) warned the UK Government that continuing to ignore the concerns of the scientific community over the proposed Human Tissue Bill could cut off vital avenues of research into understanding disease.

26 Apr 2004

Pentagon tests breakthrough system to detect airborne toxins

"Knowing how to properly respond to an attack or a toxic industrial incident requires the best modeling tools and sensors available today, and these must all work in a coordinated fashion in real time," says NCAR project leader Scott Swerdlin.

26 Apr 2004

New cancer drug Tarceva - a breakthrough with significant survival benefit in patients with advanced lung cancer

OSI Pharmaceuticals, Inc., Genentech, Inc., and Roche today announced that a Phase III study of Tarceva™ (erlotinib HCl), an investigational HER1/EGFR-inhibitor agent in previously treated patients with non-small cell lung cancer (NSCLC), met its primary endpoint of improving overall survival, with patients receiving Tarceva™ living longer than those in the placebo arm of the study.

26 Apr 2004

A new study is better defining the impact that stress and depression have on women suffering from rheumatoid arthritis

A new study is better defining the impact that stress and depression have on women suffering from rheumatoid arthritis (RA). The research, led by a team of ASU psychologists, shows increased pain and inflammation for those dealing with high amounts of stress and depression.

26 Apr 2004